Astramembrannin II - Revision history

Toyama at 05:52, 4 March 2010

2010-03-04T05:52:51Z

Toyama at 05:52, 4 March 2010

2010-03-04T05:52:27Z

Toyama: New page: {{Hierarchy|{{PAGENAME}}}} {{Metabolite |SysName=(3beta,6alpha,16beta,24R)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl-beta-D-xylopyranoside |Common Name=&&Astramembrannin II&&...

2010-03-04T05:48:43Z

New page: {{Hierarchy|{{PAGENAME}}}} {{Metabolite |SysName=(3beta,6alpha,16beta,24R)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl-beta-D-xylopyranoside |Common Name=&&Astramembrannin II&&...

New page

{{Hierarchy|{{PAGENAME}}}}

{{Metabolite
|SysName=(3beta,6alpha,16beta,24R)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl-beta-D-xylopyranoside
|Common Name=&&Astramembrannin II&&1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene .beta.-D-xylopyranoside deriv.&&9,19-Cyclolanostane .beta.-D-xylopyranoside deriv.&&Cyclosiversigenin 3-O-beta-D-xylopyranoside&&
|CAS=83207-60-7
|KNApSAcK=
}}

==Spectroscopic Data==

{| class="wikitable" style="width:80%"
|-
| '''M.P.''' || 289 - 290 °C
|-
| '''1H-NMR''' ((CDCl3+C5D5N)|| 0.33 (d, ''J''=4.0 Hz, H-19A), 0.51 (d, ''J''=4.0 Hz, H-19B), 0.96 (s, CH3), 1.14 (s, CH3), 1.23 (s, CH3), 1.26 (s, CH3), 1.35 (s, CH3), 3.25 (m, H-3alpha), 4.10 (m, H-5eq of Xyl), 4.57 (d, ''J''=7.5 Hz, H-1 of Xyl), 4.27 (m, H-16alpha)
|-
| '''13C-NMR'''|| C-2) 30.4, (3) 88.7, (4) 42.7, (5) 54.0, (6) 68.1, (7) 38.7, (16) 73.5, (20) 87.2, (24) 81.7, (25) 71.3 '''Xyl''' (1) 107.7, (2) 75.6, (3) 78.5, (4) 71.3, (5) 67.0
|}
C. Yu Qun et al., Huaxue Xuebao, 43, 581 (1985).

@@ Line 15: / Line 15: @@
 | '''M.P.''' || 289 - 290 °C
 |-
-| '''<sup>1</sup>H-NMR''' ((CDCl<sub>3</sub>+C<sub>5</sub>D<sub>5</sub>N)|| 0.33 (d, ''J''=4.0 Hz, H-19A), 0.51 (d, ''J''=4.0 Hz, H-19B), 0.96 (s, CH<sub>3</sub>), 1.14 (s, CH<sub>3</sub>), 1.23 (s, CH<sub>3</sub>), 1.26 (s, CH<sub>3</sub>), 1.35 (s, CH<sub>3</sub>), 3.25 (m, H-3alpha), 4.10 (m, H-5eq of Xyl), 4.57 (d, ''J''=7.5 Hz, H-1 of Xyl), 4.27 (m, H-16alpha)
+| '''<sup>1</sup>H-NMR''' (CDCl<sub>3</sub>+C<sub>5</sub>D<sub>5</sub>N)|| 0.33 (d, ''J''=4.0 Hz, H-19A), 0.51 (d, ''J''=4.0 Hz, H-19B), 0.96 (s, CH<sub>3</sub>), 1.14 (s, CH<sub>3</sub>), 1.23 (s, CH<sub>3</sub>), 1.26 (s, CH<sub>3</sub>), 1.35 (s, CH<sub>3</sub>), 3.25 (m, H-3alpha), 4.10 (m, H-5eq of Xyl), 4.57 (d, ''J''=7.5 Hz, H-1 of Xyl), 4.27 (m, H-16alpha)
 |-
 | '''<sup>13</sup>C-NMR'''|| C-2) 30.4, (3) 88.7, (4) 42.7, (5) 54.0, (6) 68.1, (7) 38.7, (16) 73.5, (20) 87.2, (24) 81.7, (25) 71.3 '''Xyl''' (1) 107.7, (2) 75.6, (3) 78.5, (4) 71.3, (5) 67.0
 |}
 <small>C. Yu Qun et al., Huaxue Xuebao, 43, 581 (1985).</small>

@@ Line 3: / Line 3: @@
 {{Metabolite
 |SysName=(3beta,6alpha,16beta,24R)-20,24-Epoxy-6,16,25-trihydroxy-9,19-cyclolanostan-3-yl-beta-D-xylopyranoside
-|Common Name=&&Astramembrannin II&&1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene .beta.-D-xylopyranoside deriv.&&9,19-Cyclolanostane .beta.-D-xylopyranoside deriv.&&Cyclosiversigenin 3-O-beta-D-xylopyranoside&&
+|Common Name=&&Astramembrannin II&&1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene beta-D-xylopyranoside deriv.&&9,19-Cyclolanostane beta-D-xylopyranoside deriv.&&Cyclosiversigenin 3-O-beta-D-xylopyranoside&&
 |CAS=83207-60-7
 |KNApSAcK=